Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 2Mouth Neoplasms 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 7Cisplatin 7Magnetic Resonance Spectroscopy 6Specimen Handling 5Radiotherapy, Intensity-Modulated 4Carboplatin 4Taxes 3Radiotherapy 3Platinum 3Paclitaxel 31,2-diaminocyclohexaneplatinum II citrate 3durvalumab 2Optical Imaging 2Nivolumab 2Biopsy 2peposertib 1niraparib 1nabiximols 1ipatasertib 1dostarlimab 1dehydroftorafur 1cemiplimab 1atezolizumab 1X-Rays 1Tretinoin 1Surveys and Questionnaires 1Spectrometry, Fluorescence 1Radiosurgery 1Radiation 1Proflavine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Mouth Neoplasms × Tretinoin × Clear all
NCT06728631 2025-02-24

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2 Active not recruiting
22 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡